SARS-CoV-2 (COVID-19) Nucleocapsid Antilichaam [3866]

Virus

These newer COVID-19 nucleoprotein Mabs were developed using a recombinant, full-length nucleoprotein and then confirmed that they are reactive with the native virus itself.

3866

Unconjugated

Primary Antibodies

Infectious Disease, COVID-19

Coronavirus Nucleocapsid Antibody is purified from ascites fluid or culture medium by protein A chromoatography or sequential differential precipitations.

Batch dependent

Coronavirus Nucleocapsid Antibody is in a phosphate saline buffer (0.01M, pH 7.2) containing 0.1% sodium azide preservative. No stabilizing proteins have been added.

None

Blue Ice

Coronavirus Nucleocapsid Antibody can be stored at -20˚ C, stable for one year.

Mouse IgG1

Specific for the nucleocapsid of Covid-19 virus. Cross reacts with SARS. These antibodies are non-reactive with: Influenza A, Influenza B, Adenovirus and MERS.

Suggested starting ranges are 1:10-1:50 for IFA and 1:20-1:200 for ELISA. BEST ELISA pairs (capture-conjugate) : clones 3865-3866 / 3869-3866

Coronavirus Nucleocapsid, SARS

ELISA, IF

Liquid